Quarterly Result13 Nov 2025, 02:18 pm
Granules India Ltd Reports Q2FY26 Revenue of INR 12,970 Mn, Up 34% YoY
AI Summary
Granules India Ltd., a vertically integrated pharmaceutical company, announced its financial results for the quarter ended September 30, 2025. The company reported a revenue from operations of INR 12,970 Mn, a growth of 34% YoY. The EBITDA stood at INR 2,782 Mn, up 37% YoY, and the PAT was INR 1,306 Mn, up 34% YoY. The company's ROCE is at 16.2% and net debt stood at INR 10,241 Mn with a net debt to EBITDA at 0.98x.
Key Highlights
- Q2FY26 Revenue from operations at INR 12,970 Mn, up 34% YoY
- EBITDA at INR 2,782 Mn, up 37% YoY
- PBT at INR 1,759 Mn, up 37% YoY
- PAT at INR 1,306 Mn, up 34% YoY
- ROCE at 16.2% (Post Acquisition of Senn Chemicals AG)